190 related articles for article (PubMed ID: 19234882)
21. Curettage with cement augmentation of large bone defects in giant cell tumors with pathological fractures in lower-extremity long bones.
Gupta SP; Garg G
J Orthop Traumatol; 2016 Sep; 17(3):239-47. PubMed ID: 26879890
[TBL] [Abstract][Full Text] [Related]
22. Giant cell tumor of long bone: a Canadian Sarcoma Group study.
Turcotte RE; Wunder JS; Isler MH; Bell RS; Schachar N; Masri BA; Moreau G; Davis AM;
Clin Orthop Relat Res; 2002 Apr; (397):248-58. PubMed ID: 11953616
[TBL] [Abstract][Full Text] [Related]
23. Bone defects following curettage do not necessarily need augmentation.
Hirn M; de Silva U; Sidharthan S; Grimer RJ; Abudu A; Tillman RM; Carter SR
Acta Orthop; 2009 Feb; 80(1):4-8. PubMed ID: 19234881
[TBL] [Abstract][Full Text] [Related]
24. Surgical consideration for benign bone tumors.
Eyesan SU; Idowu OK; Obalum DC; Nnodu OE; Abdulkareem FB
Niger J Clin Pract; 2011; 14(2):146-50. PubMed ID: 21860128
[TBL] [Abstract][Full Text] [Related]
25. Functional results after giant cell tumor operation near knee joint and the cement radiolucent zone as indicator of recurrence.
Kafchitsas K; Habermann B; Proschek D; Kurth A; Eberhardt C
Anticancer Res; 2010 Sep; 30(9):3795-9. PubMed ID: 20944172
[TBL] [Abstract][Full Text] [Related]
26. Giant-cell tumour of bone. The long-term results of treatment by curettage and bone graft.
Zhen W; Yaotian H; Songjian L; Ge L; Qingliang W
J Bone Joint Surg Br; 2004 Mar; 86(2):212-6. PubMed ID: 15046435
[TBL] [Abstract][Full Text] [Related]
27. Treatment of giant-cell tumors of long bones with curettage and bone-grafting.
Blackley HR; Wunder JS; Davis AM; White LM; Kandel R; Bell RS
J Bone Joint Surg Am; 1999 Jun; 81(6):811-20. PubMed ID: 10391546
[TBL] [Abstract][Full Text] [Related]
28. [Clinical observation on nano-hydroxyapatite and polyamide 66 composite in repairing bone defect due to benign bone tumor].
Liang X; Jiang D; Ni W
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Aug; 21(8):785-8. PubMed ID: 17882867
[TBL] [Abstract][Full Text] [Related]
29. Treatment of benign and borderline bone tumors with combined curettage and bone defect reconstruction.
Horstmann PF; Hettwer WH; Petersen MM
J Orthop Surg (Hong Kong); 2018; 26(3):2309499018774929. PubMed ID: 30428758
[TBL] [Abstract][Full Text] [Related]
30. Late sarcoma development after curettage and bone grafting of benign bone tumors.
Picci P; Sieberova G; Alberghini M; Balladelli A; Vanel D; Hogendoorn PC; Mercuri M
Eur J Radiol; 2011 Jan; 77(1):19-25. PubMed ID: 20828957
[TBL] [Abstract][Full Text] [Related]
31. Mid-term results of intralesional extended curettage, cauterization, and polymethylmethacrylate cementation in the treatment of giant cell tumor of bone: A retrospective case series.
Şirin E; Akgülle AH; Topkar OM; Sofulu Ö; Baykan SE; Erol B
Acta Orthop Traumatol Turc; 2020 Sep; 54(5):524-529. PubMed ID: 33155564
[TBL] [Abstract][Full Text] [Related]
32. Mid-term outcome after curettage with polymethylmethacrylate for giant cell tumor around the knee: higher risk of radiographic osteoarthritis?
van der Heijden L; van de Sande MA; Heineken AC; Fiocco M; Nelissen RG; Dijkstra PD
J Bone Joint Surg Am; 2013 Nov; 95(21):e159. PubMed ID: 24196471
[TBL] [Abstract][Full Text] [Related]
33. Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing. A Scandinavian Sarcoma Group study.
Vult von Steyern F; Bauer HC; Trovik C; Kivioja A; Bergh P; Holmberg Jörgensen P; Follerås G; Rydholm A;
J Bone Joint Surg Br; 2006 Apr; 88(4):531-5. PubMed ID: 16567792
[TBL] [Abstract][Full Text] [Related]
34. Complete local tumor control after curettage of chondroblastoma-a retrospective analysis.
Tiefenboeck TM; Stockhammer V; Panotopoulos J; Lang S; Sulzbacher I; Windhager R; Funovics PT
Orthop Traumatol Surg Res; 2016 Jun; 102(4):473-8. PubMed ID: 27067177
[TBL] [Abstract][Full Text] [Related]
35. Filling of the resultant cavity after curettage of benign bone tumours is still controversial.
Ismail TB; Mahmoud MM; Ahmed OE; Bola AH; Bahaa ZH
Med J Malaysia; 2023 Mar; 78(2):163-170. PubMed ID: 36988525
[TBL] [Abstract][Full Text] [Related]
36. Management of giant cell tumor of bone: computerized tomography based selection strategy and approaching the lesion through the site of cortical break.
Puthoor DK; Puthezhath K
Orthop Surg; 2012 May; 4(2):76-82. PubMed ID: 22615151
[TBL] [Abstract][Full Text] [Related]
37. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
[TBL] [Abstract][Full Text] [Related]
38. How to Fill the Cavity after Curettage of Giant Cell Tumors around the Knee? A Multicenter Analysis.
Zheng K; Yu XC; Hu YC; Wang Z; Wu SJ; Ye ZM;
Chin Med J (Engl); 2017 Nov; 130(21):2541-2546. PubMed ID: 29067952
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
Medellin MR; Fujiwara T; Tillman RM; Jeys LM; Gregory J; Stevenson JD; Parry M; Abudu A
Bone Joint J; 2018 Dec; 100-B(12):1626-1632. PubMed ID: 30499317
[TBL] [Abstract][Full Text] [Related]
40. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
